Biomedicine has entered the era of biofunctional biomaterials [1][2][3][4][5][6]. These are materials that utilize biophysical (e.g., topography [7][8][9][10][11][12]), biochemical (e.g., drug delivery [13-18]) and biological (e.g., gene delivery [19-24]) signals to control cellular functions in both in vitro and in vivo setting. In vitro, biofunctional materials aspire to either maintain the phenotype fidelity of permanently differentiated cells or direct stem cells toward specific lineage. In vivo, biofunctional materials desire to positively interact with host cells and surrounding tissues and promote functional repair and regeneration. The former frequently utilizes a structured substrate (e.g., electro-spun scaffolds, imprinted substrates) that would imitate the topographical/ architectural features of the tissue from which the cells were derived from (in the case of permanently differentiated cells) or the tissue that the cells are due to be implanted in (in the case of stem cells). The latter often uses a delivery vehicle (e.g., hydrogels, particles, dendrimers, micelles) that would support sustained and localized delivery of its cargo (e.g., cells, drugs, genes, growth factors).Electro-spun scaffolds and imprinted substrates have become an inherent element of modern biomedicine [25][26][27][28][29][30]. Indicative recent highlights of the electro-spinning technology include: formation of three-dimensional structures of controlled porosity [31], production of substrates for the differentiation of stem cells toward specific lineage [32], fabrication of delivery vehicles of biofunctional molecules for hypertrophic scars [33], development of high sensitivity acoustic sensors [34], assembly of high-performance lithium ion batteries [35]. Although nanoto microscale imprinted substrates did not bring about the anticipated effect in in vivo setting [36,37], numerous advances have been achieved recently, including: development of substrates with optimal dimensionality for osteogenic differentiation of human bone marrow stem cells [38], fabrication of electrode arrays to monitor the dopaminergic differentiation of human neural stem cells [39], production of electro-conductive nano-patterned substrates with enhanced myogenic differentiation and maturation capacity [40], construction of microfluidic devices [41], even manufacturing of high-performance lithium-ion micro-batteries [42]. The multimodal capacity/potential of structured technologies is undeniable. Refinement of engineering and manufacturing technologies in the years to come would enable more accurate and reproducible production of structured substrates at high volume and low cost, revolutionizing that way multiple disciplines, including biomedicine, filtration, imaging, energy and computing.Modern biomedicine requires localized and sustained delivery of bioactive molecules, therapeutic agents, trophic factors and viable cell populations to activate/enhance the innate reparative host capacity. The rationale of using delivery vehicles is based on the fa...